Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

LLPGE1 evaluated in pilot study; findings will be applied to future studies

Sep. 4, 1998

Alprostadil alfadex is a promising treatment for ED

Sep. 4, 1998

DW-2282: active enantiomer of DW-2143 and potent antitumor agent

Sep. 4, 1998

Merck KGaA synthesizes new PDE V inhibitor with potential for treating ED

Sep. 4, 1998

Potent mixed delta/mu-opioid agonist identified by Glaxo Wellcome/Delta team

Sep. 4, 1998

Taisho discovers potent and selective CRF1 receptor antagonists with anxiolytic effects

Sep. 4, 1998

Omapatrilat effective therapy for patients with chronic heart failure

Sep. 4, 1998

Receptor-selective retinoids under study at BMS

Sep. 3, 1998

Cytotoxic gigantecin analogue presented at ACS meeting

Sep. 3, 1998

WHI reports design, synthesis and pharmacological evaluation of new agent for glioblastoma

Sep. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...